Your baby is receiving a modified natural surfactant. Several brands are available. It is given to replace what your baby's lungs did not make before birth. Using surfactant has been shown to …

Surfactant replacement therapy (SRT) plays a pivotal role in the management of neonates with respiratory distress syndrome (RDS) because it improves survival and reduces respiratory …

2014年1月1日 · Surfactant treatment improves oxygenation and reduces the need for ECMO without an increase in morbidity in neonates with meconium aspiration syndrome (LOE 2). …

Surfactant deficiency is a recognized cause of respiratory distress syndrome in the preterm neonate. Secondary surfactant deficiency also contributes to acute respiratory morbidity in late …

2019年3月12日 · Surfactant treatments together with antenatal corticosteroid treatments are uniformly viewed as the most important pharmacological interventions to improve outcomes of …

Surfactant has revolutionized the treatment of respiratory distress syndrome and some other respiratory conditions that affect the fragile neonatal lung. Despite its widespread use, the …

2023年6月12日 · Surfactant is prophylactically administered in neonates at risk of developing NRDS. This activity will discuss the biochemical structure of surfactant, their administration, …

Exogenous surfactant therapy has become well established in newborn infants with respiratory distress. Many aspects of its use have been well evaluated in high-quality trials and systematic …

Background: Surfactant deficiency is the primary cause of infant respiratory distress syndrome. Exogenous surfactant administration lowers the alveolar surface tension, stabilizing the alveoli …

To provide guidance on surfactant administration in preterm and term neonates who either present with, or are at high risk of developing, surfactant deficiency respiratory distress …